✦ LIBER ✦

Bapineuzumab may be first disease-modifying AD drug

Book ID: 120843483
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816470-00060

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Microtubule-stabilising drugs may be the

Microtubule-stabilising drugs may be therapeutic in AD

✍ Roxanne Nelson 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 39 KB

Disease-modifying trial in Alzheimer's D

Disease-modifying trial in Alzheimer's Disease (AD): What should be the place of cognitive testing?

✍ Jacques Touchon 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Adding interferon (IFN)-γ to first-line

Adding interferon (IFN)-γ to first-line chemotherapy may be beneficial in ovarian cancer,

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Disease-modifying drugs for knee osteoar

Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

✍ Losina, E.; Daigle, M.E.; Suter, L.G.; Hunter, D.J.; Solomon, D.H.; Walensky, R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 697 KB

Olfactory loss may be a first sign of id

Olfactory loss may be a first sign of idiopathic Parkinson's disease

✍ Antje Haehner; Thomas Hummel; Cornelia Hummel; Ulrike Sommer; Susann Junghanns; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

## Abstract Recent studies support the idea of olfactory dysfunction as a very early sign of idiopathic Parkinson's disease (IPD). Aim of the present study was to clinically follow‐up patients with idiopathic hyposmia to find out the percentage of patients developing IPD after 4 years time. At base

Reappraisal, overhaul of disease theorie

Reappraisal, overhaul of disease theories and drug therapy methods may be due

📂 Article 📅 1967 🏛 American Chemical Society 🌐 English ⚖ 467 KB